Cellumen and Drug Safety Executive Council Announce Findings from In Vitro Discovery Toxicology Webinar
News Feb 02, 2009
Cellumen, Inc., a discovery toxicology company, and the Drug Safety Executive Council (DSEC) announced findings from “Using In Vitro Methods to Predict In Vivo Toxicity: Where Are We, Where Do We Need to Go?” a webinar held on Jan. 15, 2009.
During the webinar, participants were polled on four key areas of focus. Of responding participants:
• 54 percent of respondents felt that hit-to-lead was the stage of drug development where early toxicity assessment is most valuable;
• 75 percent of respondents believe that both rodent-predictive in vitro models and human-predictive in vitro models are important;
• 23 percent of participating organizations will spend up to $100,000 in early in vitro toxicology testing in 2009; and
• 33 percent of participating organizations plan to spend up to 35 percent of their budget for early in vitro toxicology on an outsource basis.
The webinar was moderated by Ernie Bush, Ph.D., Vice President of Collaborative Projects for the DSEC, and attended by more than 170 participants.
Joining Dr. Bush on the panel were: David Brewster, Ph.D., Vice President of Preclinical Safety at F. Hoffman La Roche; Patricia “Kate” Johnston, Ph.D., CSO and Vice President of Collaborative Development at Cellumen; Klaus Krauser, Ph.D., Senior Director of Drug Safety Evaluation at Arena Pharmaceuticals; Warren W. Ku, Ph.D., Senior Director and Head of Exploratory Safety Differentiation at Pfizer Global R&D; and Laszlo Urban, MD, Ph.D., Global Head of Preclinical Safety Profiling at Novartis (NIBR).
“I am honored to have been a part of such a distinguished panel discussion,” says Dr. Johnston. “On this panel, we emphasized the importance of realizing value and reducing the amount of money spent on drug development. These findings only confirm the importance of identifying toxic compounds earlier in drug discovery. Cellumen currently provides the industry the necessary tools to re-evaluate the drug pipeline, and in turn, save significant amounts of money annually.”
New Speakers from Roche and Imperial College London Announced for SMi’s ADMET EventNews
SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE
Chemists Design 'Mini-ecosystems' to Test Drug FunctionNews
Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.READ MORE
Comments | 0 ADD COMMENT
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018